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Abstract 
Experience with endoscopic retrograde cholangiopancreatography in the pediatric population is limited. The aim of 
this study was to evaluate the outcomes of ERCP in the pediatric population performed by adult gastroenterologists 
with standard duodenoscopes. This study is a structured retrospective review of endoscopic reports, computerized 
and paper medical records, and radiographic images of patients under the age of 18 who underwent ERCP for any 
indication at a tertiary referral centre. Data regarding demographic characteristics and medical history of patients, 
indications, technical success rate, final clinical diagnosis, and complications were analyzed. Forty-eight children with 
a mean age of 13 years (range 2–17) underwent a total of 65 ERCPs. The indications of ERCP were as follows; sus-
pected choledocholithiasis (55 %), post-liver transplantation anastomotic biliary strictures (21 %), post-surgical bile 
duct injury (10 %), choledochal cyst (2 %), recurrent or chronic pancreatitis (10 %), and trauma (2 %). The cannulation 
success rate in the overall procedure was 93.8 %. Therapeutic interventions were performed in 70.7 % of patients. 
Post ERCP pancreatitis was the most common complication occurring in 9.2 % of patients, and no procedure related 
mortality occurred. When performed by well-trained adult gastroenterologists, the use of endoscopic retrograde 
cholangiopancreatography with standard duodenoscopes is safe in pediatric population.
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Background
Endoscopic retrograde cholangiopancreatography 
(ERCP) has long been established as an effective diagnos-
tic and therapeutic modality for pancreaticobiliary disor-
ders in the adult population (Adler et al. 2005). In Waye 
1976 reported the first successful ERCP in a 3.5-month-
old child with cholestasis using a standard duodenoscope 
(Waye 1976). The use of ERCP in pediatric population 
was limited; however, since the development of smaller 
diameter duodenoscopes and accessories in late 80 s, its 
use has grown considerably (Allendorph et al. 1987; Fox 
et al. 2000). Experience was limited due to multiple fac-
tors, including the relatively low incidence of diseases 
requiring ERCP in this age group and the impression that 
the procedure is technically difficult in children. Addi-
tionally, the indications and safety of ERCP in children 
have not been well defined (Hsu et al. 2000).
The aim of the present study was to evaluate the indica-
tions, results, and safety of ERCP in pediatric population 
performed by adult gastroenterologists with standard 
duodenoscopes.
Methods
This study is a structured retrospective review of medical 
records of patients under the age of 18 who underwent 
ERCP in Baskent University Department of Gastroenter-
ology between 2001 and 2012. This chart and computer-
based study was approved by the Baskent University 
Institutional Review Board.
All procedures were performed by the same gastro-
enterologists with appropriate training and expertise 
in ERCP. Procedures were done at the Baskent Univer-
sity Ankara Hospital, a tertiary centre with expertise in 
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solid organ transplantation and hepatobiliary surgery. 
Informed written consent was obtained from the legal 
guardian of the patients. All patients were placed under 
deep sedation by an anesthesiologist and the procedures 
were performed in the prone position.
For all patients, a diagnostic adult duodenoscope (TJF-
160; Olympus America Corp., Melville, NY, USA) with an 
insertion diameter of 10.8 mm or a therapeutic duodeno-
scope (TJF-100; Olympus America Corp., Melville, NY, 
USA) with an insertion diameter of 12.5 mm was used at 
the discretion of the gastroenterologist. Technical suc-
cess was defined as a successful deep cannulation of the 
bile duct or pancreatic duct along with completion of any 
planned diagnostic or therapeutic procedure. Cannula-
tion was achieved using a tapered tip cannulation cath-
eter with a guidewire. Sphincterotomy was performed in 
standard fashion. Stone removal was achieved using the 
passage of Fogarty-type balloon. Ductal clearance was 
documented with balloon occlusion cholangiogram. For 
patients in whom ductal clearance was not achieved, a 
plastic biliary stent was placed in the standard fashion.
Complications were defined as occurring within 
2  weeks of the procedure and were further categorized 
as bleeding (in which endoscopic therapy and/or blood 
transfusion was required), perforation, post-ERCP pan-
creatitis, cholangitis, abdominal pain in the absence of 
cholangitis and/or pancreatitis, and death.
Data regarding demographic characteristics and medi-
cal history of patients, indications, technical success rate, 
final clinical diagnosis, ERCP interventions performed, 
and complications were obtained from the hospital elec-
tronic medical records database and retrospectively 
analyzed.
IBM SPSS Statistics 19 (SPSS, Inc., Chicago, IL, 
USA) program was used for statistical analysis. Results 
were presented as median (minimum–maximum) and 
percentages.
Results
Over the 10-year study period, 65 ERCPs were per-
formed, including 33 (51  %) diagnostic and 32 (49  %) 
therapeutic procedures on 48 children at our institution. 
There were 20 (42 %) girls and 28 (58 %) boys aged from 
2 to 17 years. The median age was 13 years (2–17 years). 
Also, 42  % (n  =  20) were pre-adolescence and 48  % 
(n  =  28) were teenagers. The majority of the patients 
(n = 37) underwent a single procedure, 7 underwent two 
procedures, 3 underwent three procedures and 1 under-
went five procedures (Table 1).
Of all procedures, 91  % were for biliary and 9  % for 
pancreatic indications. The biliary indications were sus-
pected choledocholithiasis (55 %), post liver transplanta-
tion anastomotic biliary strictures (21  %), post-surgical 
bile duct injury (10 %), and choledochal cyst (2 %). The 
pancreatic indications included recurrent or chronic 
pancreatitis (10 %) and trauma (2 %). The final diagnoses 
after the procedure are demonstrated in Table 2. A nor-
mal cholangiography was found in 22.9 % of ERCPs.
An overall procedure, papilla cannulation success rate 
was 93.8  %. Cannulation success rate per patient was 
91.7  % (44 of 48 patients). Of these 44 patients, 93.2  % 
resulted in successful cannulation in first ERCP pro-
cedure and 6.8  % in second procedure. Additionally, 
successful cannulation was achieved 88.6  % (39 of 44 
patients) with standard cannulation techniques. In five 
patients (11.4  %), pre-cut sphincterotomy (with nee-
dle-knife in 1 patient and standard sphincterotome in 4 
patients) was performed when standard techniques fail to 
achieve cannulation (Table 3).
Therapeutic interventions were performed in 70.7 % of 
patients including sphincterotomy in 38 patients (58.5 %), 
balloon sweep in 17 patients (26.1  %), biliary plastic 
stent insertion 12 patients (18.5 %), stone extraction in 8 
patients (12.3 %), nasobiliary drainage tube placement in 
6 patients (9.2 %), and balloon dilatation of biliary stric-
tures in 1 patient (1.5 %) (Table 4).
The complication rate was 12.3 % (8 of 65 procedures) 
per procedure and 16.6 % (8 of 48 patients) per patients. 
Complications are summarized in Table  5. Post ERCP 
pancreatitis was the most common complication, with an 
occurrence rate of in 9.2 %. All six patients were graded 
as mild pancreatitis according to the consensus classifi-
cation of post-ERCP pancreatitis by Cotton et al. (1991), 
and all resolved with conservative treatment. Bleeding 
occurred in 2 patients (3.1 %) and controlled with endo-
scopic management. Delayed hemorrhage did not occur. 
No severe pancreatitis, bleeding, perforation and infec-
tion occurred. There was no procedure related mortality.
Discussion
In present study, the rate of technical success and the rate 
of complications found in pediatric ERCP were in con-
cordance with previously reported large series (Cheng 
et  al. 2005; Giefer and Kozarek 2015; Enestvedt et  al. 
Table 1 Patients’ demographics
Gender (%)
 Female 20 (42 %)
 Male 28 (58 %)
Median age (max–min) 13 (2–17)
ERCP procedures (%)
 Diagnostic 33 (51 %)
 Therapeutic 32 (49 %)
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2013; Troendle and Barth 2013, 2015; Halvorson et  al. 
2013; Otto et al. 2011; Jang et al. 2010; Iqbal et al. 2009) 
(Table  6). We suggest that ERCP is a safe and effective 
method for both the diagnosis and treatment of pediatric 
patients.
When performed by experienced endoscopists, ERCP 
has an acceptable complication rate in the adult popula-
tion (Rabenstein et al. 1999). In the pediatric population, 
experience with ERCP has been limited due to multiple 
factors including a relatively low incidence of diseases 
requiring ERCP and the impression that the procedure is 
technically difficult in children. Additionally, the indica-
tions and safety of ERCP in the pediatric population have 
not been well defined. Few pediatric gastroenterologists 
receive sufficient training on advanced endoscopy includ-
ing procedures such as ERCP. This gap is generally filled 
by adult gastroenterologists.
The main problem is that most adult endoscopy units 
do not have pediatric duodenoscopes. Pediatric duo-
denoscopes are recommended for children <10  kg or 
younger than 12  months of age, beyond which an adult 
diagnostic or therapeutic duodenoscope is acceptable 
(ASGE Technology Committee et  al. 2012). However, a 
diagnostic duodenoscope or a therapeutic duodenoscope 
was used at the discretion of the gastroenterologist in 
this study, and no complications such as tracheal impres-
sions, airway obstruction, nor the necessity of endotra-
cheal intubation occurred.
In Western countries, the most common indications 
for ERCP are choledocholithiasis and acute or chronic 
pancreatitis whereas the most frequent indication in 
Eastern countries (Japan, Korea and India) is congeni-
tal choledochal cysts (Cheng et al. 2005; Pfau et al. 2002; 
Teng et  al. 2000; Issa et  al. 2007; Jang et  al. 2010; Otto 
et  al. 2011). The most common indication in this study 
was choledocholithiasis. Additionally because of Baskent 
University hospital is a tertiary centre with expertise in 
solid organ transplantation, post-liver transplantation 
biliary strictures had a similar frequency. Enestvedt et al. 
reported their pediatric ERCP experience in 296 children 
who underwent a total of 429 ERCPs. The most common 
indications in this series were similar to present study 
such as choledocholithiasis (26.1 %) and biliary stricture 
(26.1 %) (Enestvedt et al. 2013).
Conscious or deep sedation and topical anesthesia 
has become a safe alternative to general anesthesia in 
pediatric endoscopy (Green et  al. 2001). But the higher 
complexity and duration of the procedure in pediat-
ric patients with a smaller anatomy sometimes requires 
general anesthesia. Although the many therapeutic inter-
ventions were applied to our pediatric patients and the 
youngest patient was 2  years old, none of our patients 
required general anesthesia. Conscious or deep seda-
tion were preferred for all patients unlike other pediat-
ric series (Cheng et al. 2005; Paris et al. 2010; Halvorson 
et al. 2013; Troendle and Barth 2013). There were also no 
Table 2 Final diagnosis after ERCP
n (%)
Choledocholithiasis 12 (25 %)
Post-liver transplantation biliary strictures 11 (22.9 %)
Normal 11 (22.9 %)
Post-surgical bile duct injury 3 (6.2 %)
Biliary strictures 2 (4.1 %)
Pancreas divisium 2 (4.1 %)
Choledochal cyst 1 (2.1 %)
Chronic pancreatitis 1 (2.1 %)
Pancreatic duct injury 1 (2.1 %)
Unsuccessful ERCP 4 (8.4 %)
Table 3 ERCPs success, cannulation properties and  tech-
niques rates
N %
Overall ERCP procedures, papilla cannulation success 61 93.8 (61/65)
Cannulation success rate per patients 44 91.7 (44/48)
Successful cannulation in first ERCP procedure 41 93.2 (41/44)
Successful cannulation in second ERCP procedure 3 6.8 (3/44)
Successful cannulation with standard cannulation 
techniques
39 88.6 (39/44)
Successful cannulation with precut sphincterotomy 
techniques
5 11.4 (5/44)
Table 4 Therapeutic interventions (65 procedures in  48 
patients)
n (%)
Sphincterotomy 38 (58.5 %)
Balloon sweep 17 (26.1 %)
Biliary plastic stent insertion 12 (18.5 %)
Stone extraction 8 (12.3 %)
Nasobiliary drainage tube placement 6 (9.2 %)
Ballon dilatation of biliary strictures 1 (1.5 %)
Table 5 Complications related to ERCP
N % of total ERCP
Post ERCP pancreatits 6 9.2
Bleeding after sphincterotomy 2 3.1
Total 8 12.3
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serious adverse events such as cardiorespiratory suppres-
sion specifically related to deep sedation. These findings 
suggest that the preference between deep sedation and 
general anesthesia can be determined according to many 
factors including patient age, weight, and experience.
The most difficult aspect of the ERCP is the first step: 
selective biliary cannulation (SBC) which may often end 
in failure. The principles of SBC in children are similar to 
those used in adult patients. There are some limitations 
in pediatric patients such as phenotypic characteristics of 
age range and equipment sizes. Despite all disadvantages, 
the rate of successful cannulation is as good as compara-
ble to reports in adults (Allendorph et al. 1987; Guelrud 
et  al. 1994; Otto et  al. 2011). Success rates of pediatric 
ERCP were reported 89.5–100 % in previous studies (Teng 
et al. 2000; Paris et al. 2010; Green et al. 2007; Cheng et al. 
2005; Giefer and Kozarek 2015; Enestvedt et al. 2013). The 
success rate in this study is similar to those in previous 
reports. Cannulation was unsuccessful in four patients, 
all of whom were younger than five. The diameter of the 
ERCP catheter and the sphincterotome is larger than the 
diameter of the papilla. In our experience, this diameter 
mismatch increases the difficulty of achieving selective 
bile duct cannulation in small children and infants.
There were a remarkable amount of therapeutic inter-
ventions (70.7 %) in this pediatric patient series. In most 
of the procedures, more than one intervention was per-
formed including sphincterotomy with balloon sweep or 
sphincterotomy or balloon sweep with subsequent biliary 
plastic stent insertion.
The overall complication rate found in the present 
study (12.3  %) reflected the findings found in literature 
with regard to adult and pediatric patients (1 %-17,5 %) 
(Allendorph et al. 1987; Cotton et al. 1991; Cheng et al. 
2005; Pfau et al. 2002; Teng et al. 2000; Paris et al. 2010; 
Halvorson et al. 2013; Enestvedt et al. 2013). Post-ERCP 
pancreatitis, the most common ERCP-related compli-
cation in children, was found to occur in 9.2  % of total 
ERCP in this study, which is similar to the incidence typi-
cally reported in early series (3–17  %) (Fox et  al. 2000). 
Cheng et  al. reported that the rate of pancreatitis after 
therapeutic ERCP was higher than diagnostic ERCP (11.1 
vs 5.4 %, respectively) (Cheng et al. 2005). The occurrence 
of pancreatitis in our patient population may be associ-
ated with the high rate of therapeutic interventions. The 
reported incidence of other complications are as follows; 
hemorrhage 1–4  %, perforation 1–2  %, and cholangitis 
1–5 % (Freeman et al. 1996; Masci et al. 2001; Feurer and 
Adler 2012; Vandervoort et  al. 2002; Wang et  al. 2009). 
Post-ERCP complication rates vary widely depending on 
the complexity of the intervention.
This study has several limitations that should be 
noted. First, it is retrospective nature. Complete medical 
reports such as weight and BMI percentile of the pedi-
atric patients were not available on all patients. Because 
of the fact that our facility was a referral centre, followup 
was shorter than 30 days. Short follow-ups consequently 
led to limited information retrieval on the effect of post 
ERCP in survival, late complications, and recurrence of 
the presenting disease. It is a single-center study from a 
tertiary referral centre. Therefore, the outcomes of this 
study cannot be generalized as these factors can vary 
based on local referral patterns, pre/peri/post-procedural 
medical care, and endoscopist experience.
Based on the results of our study, we suggest that diag-
nostic and therapeutic ERCP is safe and effective in the 
Table 6 Pediatric endoscopic retrograd cholangiopancreatography larger series
NR not specifically reported
References Mean age (range) Study design Endoscopist Patient (n) ERCP (n) Procedure 
success (%)
Therapeutic (%)
Giefer and Kozarek 
(2015)
13.6 years 
(2 months–18 years)
Retrospective Adult 276 425 95 81
Troendle et al. (2015) 12.7 years 
(1 months–19 years)
Retrospective Pediatric  
and adult
313 432 NR 86
Enestvedt et al. (2013) 14.9 years 
(3 months–21 years)
Retrospective Adult 296 429 95 64
Halvorson et al. (2013) 12 years (6 years–17 years) Retrospective Adult 45 70 99 93
Troendle and Barth 
(2013)
15.2 years 
(1 months–18.4 years)
Retrospective Pediatric 65 154 100 100
Otto et al. (2011) 11.4 years 
(2 months–21 years)
Retrospective Adult 167 231 NR 69
Jang et al. (2010) 8 years (1 months–16 years) Retrospective Pediatric 122 245 98 78
Iqbal et al. (2009) NR Retrospective Adult 224 343 NR 43
Cheng et al. (2005) 9.3 years 
(1 months–17 years)
Retrospective Adult 245 329 98 71
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pediatric population when performed by an experienced 
adult gastroenterologist at high-volume centers. The 
complication rates are comparable to those that observed 
in adults.
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